State Street Corp Akoya Biosciences, Inc. Call Options Transaction History
State Street Corp
- $2.8 Trillion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKYA
# of Institutions
18Shares Held
2.41MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.5MShares$1.94 Million0.0% of portfolio
-
Exodus Point Capital Management, LP New York, NY205KShares$264,8620.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il100KShares$129,6020.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny91.6KShares$118,1330.0% of portfolio
-
Northern Trust Corp Chicago, IL83.5KShares$107,7020.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $48.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...